NDC 10122-502

Revcovi

Elapegademase-lvlr

Revcovi is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Elapegademase.

• Product ID: 10122-502_4404cb41-0794-4af5-848e-163017ab951b
• NDC: 10122-502
• Product Type: Human Prescription Drug
• Proprietary Name: Revcovi
• Generic Name: Elapegademase-lvlr
• Dosage Form: Injection
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2018-10-05
• Marketing Category: BLA /
• Application Number: BLA761092
• Labeler Name: Chiesi USA, Inc.
• Substance Name: ELAPEGADEMASE
• Active Ingredient Strength: 2 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 10122-502-01

1 VIAL in 1 CARTON (10122-502-01) > 1.5 mL in 1 VIAL

• Marketing Start Date: 2018-10-05
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Revcovi" or generic name "Elapegademase-lvlr"

NDC	Brand Name	Generic Name
10122-502	Revcovi	elapegademase-lvlr
57665-002	Revcovi	elapegademase-lvlr